Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
MAIA Biotechnology Inc is a targeted therapy, immuno-oncology company focused on the development and commercialization of potential first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's lead program is THIO, a potential first-in-class cancer telomere targeting agent in clinical development for the treatment of telomerase-positive cancer cells.
| Last: | $2.2601 |
|---|---|
| Change Percent: | 5.61% |
| Open: | $2.23 |
| Close: | $2.14 |
| High: | $2.43 |
| Low: | $2.21 |
| Volume: | 592,595 |
| Last Trade Date Time: | 02/27/2026 01:21:13 pm |
| Market Cap: | $69,250,414 |
|---|---|
| Float: | 32,146,635 |
| Insiders Ownership: | 2.86% |
| Institutions: | 14 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.maiabiotech.com |
| Country: | US |
| City: | Chicago |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about MAIA Biotechnology Inc. (NYSE: MAIA).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.
Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.
